ID   ABCBB_HUMAN             Reviewed;        1321 AA.
AC   O95342; Q53TL2; Q9UNB2;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   03-NOV-2009, sequence version 2.
DT   04-FEB-2015, entry version 142.
DE   RecName: Full=Bile salt export pump;
DE   AltName: Full=ATP-binding cassette sub-family B member 11;
GN   Name=ABCB11; Synonyms=BSEP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS PFIC2 GLY-297; GLU-461;
RP   GLY-482; ARG-982; CYS-1153 AND GLN-1268.
RX   PubMed=9806540; DOI=10.1038/3034;
RA   Strautnieks S.S., Bull L.N., Knisely A.S., Kocoshis S.A., Dahl N.,
RA   Arnell H., Sokal E.M., Dahan K., Childs S., Ling V., Tanner M.S.,
RA   Kagalwalla A.F., Nemeth A., Pawlowska J., Baker A., Mieli-Vergani G.,
RA   Freimer N.B., Gardiner R.M., Thompson R.J.;
RT   "A gene encoding a liver-specific ABC transporter is mutated in
RT   progressive familial intrahepatic cholestasis.";
RL   Nat. Genet. 20:233-238(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-444.
RA   Mol O., Hooiveld G.J.E.J., Jansen P.L.M., Muller M.;
RT   "Cellular localization and functional characterization of the human
RT   bile salt export pump (BSEP).";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   GLYCOSYLATION AT ASN-109; ASN-116; ASN-122 AND ASN-125.
RX   PubMed=17082223; DOI=10.1152/ajpgi.00415.2006;
RA   Mochizuki K., Kagawa T., Numari A., Harris M.J., Itoh J., Watanabe N.,
RA   Mine T., Arias I.M.;
RT   "Two N-linked glycans are required to maintain the transport activity
RT   of the bile salt export pump (ABCB11) in MDCK II cells.";
RL   Am. J. Physiol. 292:G818-G828(2007).
RN   [5]
RP   VARIANTS PFIC2 VAL-238 AND SER-336.
RX   PubMed=10579978; DOI=10.1016/S0016-5085(99)70287-8;
RA   Jansen P.L.M., Strautnieks S.S., Jacquemin E., Hadchouel M.,
RA   Sokal E.M., Hooiveld G.J.E.J., Koning J.H., De Jager-Krikken A.,
RA   Kuipers F., Stellaard F., Bijleveld C.M., Gouw A., Van Goor H.,
RA   Thompson R.J., Muller M.;
RT   "Hepatocanalicular bile salt export pump deficiency in patients with
RT   progressive familial intrahepatic cholestasis.";
RL   Gastroenterology 117:1370-1379(1999).
RN   [6]
RP   VARIANT ALA-444.
RX   PubMed=11829140; DOI=10.1007/s10038-002-8653-6;
RA   Saito S., Iida A., Sekine A., Miura Y., Ogawa C., Kawauchi S.,
RA   Higuchi S., Nakamura Y.;
RT   "Three hundred twenty-six genetic variations in genes encoding nine
RT   members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the
RT   Japanese population.";
RL   J. Hum. Genet. 47:38-50(2002).
RN   [7]
RP   VARIANTS PFIC2 LEU-284 AND ASP-1004.
RX   PubMed=11815775; DOI=10.1067/mpd.2002.119993;
RA   Chen H.-L., Chang P.-S., Hsu H.-C., Ni Y.-H., Hsu H.-Y., Lee J.-H.,
RA   Jeng Y.-M., Shau W.-Y., Chang M.-H.;
RT   "FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic
RT   cholestasis with low gamma-glutamyltranspeptidase levels.";
RL   J. Pediatr. 140:119-124(2002).
RN   [8]
RP   VARIANTS BRIC2 GLY-186; GLY-297; THR-570; PRO-923; PRO-926; CYS-1050
RP   AND HIS-1128.
RX   PubMed=15300568; DOI=10.1053/j.gastro.2004.04.065;
RA   van Mil S.W.C., van der Woerd W.L., van der Brugge G., Sturm E.,
RA   Jansen P.L.M., Bull L.N., van den Berg I.E.T., Berger R.,
RA   Houwen R.H.J., Klomp L.W.J.;
RT   "Benign recurrent intrahepatic cholestasis type 2 is caused by
RT   mutations in ABCB11.";
RL   Gastroenterology 127:379-384(2004).
RN   [9]
RP   VARIANTS GLN-415; ALA-444; SER-591 AND VAL-677.
RX   PubMed=15077010; DOI=10.1097/00008571-200402000-00003;
RA   Pauli-Magnus C., Lang T., Meier Y., Zodan-Marin T., Jung D.,
RA   Breymann C., Zimmermann R., Kenngott S., Beuers U., Reichel C.,
RA   Kerb R., Penger A., Meier P.J., Kullak-Ublick G.A.;
RT   "Sequence analysis of bile salt export pump (ABCB11) and multidrug
RT   resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with
RT   intrahepatic cholestasis of pregnancy.";
RL   Pharmacogenetics 14:91-102(2004).
RN   [10]
RP   VARIANTS BRIC2 GLY-297 AND THR-432, AND CHARACTERIZATION OF VARIANTS
RP   BRIC2 GLY-297 AND THR-432.
RX   PubMed=16039748; DOI=10.1016/j.jhep.2005.05.020;
RA   Noe J., Kullak-Ublick G.A., Jochum W., Stieger B., Kerb R., Haberl M.,
RA   Muellhaupt B., Meier P.J., Pauli-Magnus C.;
RT   "Impaired expression and function of the bile salt export pump due to
RT   three novel ABCB11 mutations in intrahepatic cholestasis.";
RL   J. Hepatol. 43:536-543(2005).
RN   [11]
RP   VARIANTS VAL-206; ALA-284; LYS-299; ALA-444; GLY-616; ALA-619;
RP   VAL-677; HIS-698; VAL-865 AND GLN-958.
RX   PubMed=16763017; DOI=10.1124/dmd.105.008854;
RA   Lang T., Haberl M., Jung D., Drescher A., Schlagenhaufer R., Keil A.,
RA   Mornhinweg E., Stieger B., Kullak-Ublick G.A., Kerb R.;
RT   "Genetic variability, haplotype structures, and ethnic diversity of
RT   hepatic transporters MDR3 (ABCB4) and bile salt export pump
RT   (ABCB11).";
RL   Drug Metab. Dispos. 34:1582-1599(2006).
RN   [12]
RP   VARIANTS ALA-444 AND VAL-677.
RX   PubMed=16799996; DOI=10.1002/hep.21214;
RA   Meier Y., Pauli-Magnus C., Zanger U.M., Klein K., Schaeffeler E.,
RA   Nussler A.K., Nussler N., Eichelbaum M., Meier P.J., Stieger B.;
RT   "Interindividual variability of canalicular ATP-binding-cassette
RT   (ABC)-transporter expression in human liver.";
RL   Hepatology 44:62-74(2006).
RN   [13]
RP   VARIANTS ALA-284; ALA-444; TYR-676; VAL-677; HIS-698 AND ARG-855,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND CHARACTERIZATION OF VARIANTS
RP   ALA-444; TYR-676; VAL-677 AND ARG-855.
RX   PubMed=17264802; DOI=10.1097/01.fpc.0000230418.28091.76;
RA   Lang C., Meier Y., Stieger B., Beuers U., Lang T., Kerb R.,
RA   Kullak-Ublick G.A., Meier P.J., Pauli-Magnus C.;
RT   "Mutations and polymorphisms in the bile salt export pump and the
RT   multidrug resistance protein 3 associated with drug-induced liver
RT   injury.";
RL   Pharmacogenet. Genomics 17:47-60(2007).
CC   -!- FUNCTION: Involved in the ATP-dependent secretion of bile salts
CC       into the canaliculus of hepatocytes.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=30.4 uM for taurocholate {ECO:0000269|PubMed:17264802};
CC         Vmax=232 pmol/min/mg enzyme for taurocholate transport
CC         {ECO:0000269|PubMed:17264802};
CC   -!- SUBUNIT: Interacts with HAX1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed predominantly, if not exclusively in
CC       the liver, where it was further localized to the canalicular
CC       microvilli and to subcanalicular vesicles of the hepatocytes by in
CC       situ.
CC   -!- DOMAIN: Multifunctional polypeptide with two homologous halves,
CC       each containing a hydrophobic membrane-anchoring domain and an ATP
CC       binding cassette (ABC) domain.
CC   -!- DISEASE: Cholestasis, progressive familial intrahepatic, 2 (PFIC2)
CC       [MIM:601847]: A disorder characterized by early onset of
CC       cholestasis that progresses to hepatic fibrosis, cirrhosis, and
CC       end-stage liver disease before adulthood.
CC       {ECO:0000269|PubMed:10579978, ECO:0000269|PubMed:11815775,
CC       ECO:0000269|PubMed:9806540}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cholestasis, benign recurrent intrahepatic, 2 (BRIC2)
CC       [MIM:605479]: A disorder characterized by intermittent episodes of
CC       cholestasis without progression to liver failure. There is initial
CC       elevation of serum bile acids, followed by cholestatic jaundice
CC       which generally spontaneously resolves after periods of weeks to
CC       months. The cholestatic attacks vary in severity and duration.
CC       Patients are asymptomatic between episodes, both clinically and
CC       biochemically. {ECO:0000269|PubMed:15300568,
CC       ECO:0000269|PubMed:16039748}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCB
CC       family. Multidrug resistance exporter (TC 3.A.1.201) subfamily.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 ABC transmembrane type-1 domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00441}.
CC   -!- SIMILARITY: Contains 2 ABC transporter domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00434}.
CC   -!- WEB RESOURCE: Name=ABCMdb; Note=Database for mutations in ABC
CC       proteins;
CC       URL="http://abcmutations.hegelab.org/proteinDetails?uniprot_id=O95342";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF091582; AAC77455.1; -; mRNA.
DR   EMBL; AF136523; AAD28285.1; -; mRNA.
DR   EMBL; AC008177; AAY24305.1; -; Genomic_DNA.
DR   EMBL; AC093723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069137; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS46444.1; -.
DR   RefSeq; NP_003733.2; NM_003742.2.
DR   UniGene; Hs.658439; -.
DR   ProteinModelPortal; O95342; -.
DR   SMR; O95342; 18-1316.
DR   BioGrid; 114199; 6.
DR   IntAct; O95342; 2.
DR   MINT; MINT-5003953; -.
DR   STRING; 9606.ENSP00000263817; -.
DR   BindingDB; O95342; -.
DR   ChEMBL; CHEMBL6020; -.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   DrugBank; DB00559; Bosentan.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB00845; Clofazimine.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB00694; Daunorubicin.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB00390; Digoxin.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB00977; Ethinyl Estradiol.
DR   DrugBank; DB00693; Fluorescein.
DR   DrugBank; DB02703; Fusidic Acid.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB01026; Ketoconazole.
DR   DrugBank; DB01051; Novobiocin.
DR   DrugBank; DB01229; Paclitaxel.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB08901; Ponatinib.
DR   DrugBank; DB00175; Pravastatin.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00206; Reserpine.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB01098; Rosuvastatin.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB01586; Ursodeoxycholic acid.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB00570; Vinblastine.
DR   DrugBank; DB00541; Vincristine.
DR   TCDB; 3.A.1.201.2; the atp-binding cassette (abc) superfamily.
DR   PhosphoSite; O95342; -.
DR   MaxQB; O95342; -.
DR   PaxDb; O95342; -.
DR   PRIDE; O95342; -.
DR   Ensembl; ENST00000263817; ENSP00000263817; ENSG00000073734.
DR   GeneID; 8647; -.
DR   KEGG; hsa:8647; -.
DR   UCSC; uc002ueo.1; human.
DR   CTD; 8647; -.
DR   GeneCards; GC02M169743; -.
DR   GeneReviews; ABCB11; -.
DR   H-InvDB; HIX0029772; -.
DR   HGNC; HGNC:42; ABCB11.
DR   HPA; HPA019035; -.
DR   MIM; 601847; phenotype.
DR   MIM; 603201; gene.
DR   MIM; 605479; phenotype.
DR   neXtProt; NX_O95342; -.
DR   Orphanet; 99961; Benign recurrent intrahepatic cholestasis type 2.
DR   Orphanet; 69665; Intrahepatic cholestasis of pregnancy.
DR   Orphanet; 79304; Progressive familial intrahepatic cholestasis type 2.
DR   PharmGKB; PA374; -.
DR   eggNOG; COG1132; -.
DR   GeneTree; ENSGT00530000062896; -.
DR   HOVERGEN; HBG080809; -.
DR   InParanoid; O95342; -.
DR   KO; K05664; -.
DR   OMA; TIVWTNS; -.
DR   PhylomeDB; O95342; -.
DR   TreeFam; TF105193; -.
DR   Reactome; REACT_11041; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; REACT_11042; Recycling of bile acids and salts.
DR   ChiTaRS; ABCB11; human.
DR   GeneWiki; ABCB11; -.
DR   GenomeRNAi; 8647; -.
DR   NextBio; 32419; -.
DR   PRO; PR:O95342; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; O95342; -.
DR   CleanEx; HS_ABCB11; -.
DR   ExpressionAtlas; O95342; baseline and differential.
DR   Genevestigator; O95342; -.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular vesicular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0046581; C:intercellular canaliculus; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; TAS:ProtInc.
DR   GO; GO:0042626; F:ATPase activity, coupled to transmembrane movement of substances; IBA:GO_Central.
DR   GO; GO:0015432; F:bile acid-exporting ATPase activity; TAS:ProtInc.
DR   GO; GO:0015126; F:canalicular bile acid transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0008554; F:sodium-exporting ATPase activity, phosphorylative mechanism; TAS:ProtInc.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0015721; P:bile acid and bile salt transport; TAS:Reactome.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0008206; P:bile acid metabolic process; TAS:Reactome.
DR   GO; GO:0015722; P:canalicular bile acid transport; IBA:GO_Central.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; TAS:GOC.
DR   GO; GO:0055085; P:transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   Gene3D; 3.40.50.300; -; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR003439; ABC_transporter-like.
DR   InterPro; IPR017871; ABC_transporter_CS.
DR   InterPro; IPR030278; BSEP.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24221:SF165; PTHR24221:SF165; 1.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF90123; SSF90123; 3.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 1.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Disease mutation; Glycoprotein;
KW   Intrahepatic cholestasis; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1   1321       Bile salt export pump.
FT                                /FTId=PRO_0000093296.
FT   TOPO_DOM      1     62       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     63     83       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM     84    147       Extracellular. {ECO:0000255}.
FT   TRANSMEM    148    168       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    169    215       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    216    236       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    237    240       Extracellular. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    262    319       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    320    340       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    341    353       Extracellular. {ECO:0000255}.
FT   TRANSMEM    354    374       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    375    755       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    756    776       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    777    794       Extracellular. {ECO:0000255}.
FT   TRANSMEM    795    815       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    816    869       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    870    890       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TRANSMEM    891    911       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM    912    979       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    980   1000       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM   1001   1011       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1012   1032       Helical. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00441}.
FT   TOPO_DOM   1033   1321       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       62    385       ABC transmembrane type-1 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN      420    656       ABC transporter 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   DOMAIN      755   1043       ABC transmembrane type-1 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00441}.
FT   DOMAIN     1078   1316       ABC transporter 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND     455    462       ATP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   NP_BIND    1113   1120       ATP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00434}.
FT   REGION      651    672       Interaction with HAX1. {ECO:0000250}.
FT   MOD_RES     690    690       Phosphoserine. {ECO:0000250}.
FT   CARBOHYD    109    109       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:17082223}.
FT   CARBOHYD    116    116       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:17082223}.
FT   CARBOHYD    122    122       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:17082223}.
FT   CARBOHYD    125    125       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:17082223}.
FT   VARIANT      56     56       S -> L (in dbSNP:rs11568361).
FT                                /FTId=VAR_055472.
FT   VARIANT     186    186       E -> G (in BRIC2).
FT                                {ECO:0000269|PubMed:15300568}.
FT                                /FTId=VAR_030386.
FT   VARIANT     206    206       I -> V (in dbSNP:rs11568357).
FT                                {ECO:0000269|PubMed:16763017}.
FT                                /FTId=VAR_030387.
FT   VARIANT     238    238       G -> V (in PFIC2).
FT                                {ECO:0000269|PubMed:10579978}.
FT                                /FTId=VAR_030388.
FT   VARIANT     284    284       V -> A. {ECO:0000269|PubMed:16763017,
FT                                ECO:0000269|PubMed:17264802}.
FT                                /FTId=VAR_035349.
FT   VARIANT     284    284       V -> L (in PFIC2).
FT                                {ECO:0000269|PubMed:11815775}.
FT                                /FTId=VAR_013332.
FT   VARIANT     297    297       E -> G (in PFIC2 and BRIC2; reduced
FT                                transport capacity for taurocholate).
FT                                {ECO:0000269|PubMed:15300568,
FT                                ECO:0000269|PubMed:16039748,
FT                                ECO:0000269|PubMed:9806540}.
FT                                /FTId=VAR_010271.
FT   VARIANT     299    299       R -> K (in dbSNP:rs2287617).
FT                                {ECO:0000269|PubMed:16763017}.
FT                                /FTId=VAR_030389.
FT   VARIANT     336    336       C -> S (in PFIC2).
FT                                {ECO:0000269|PubMed:10579978}.
FT                                /FTId=VAR_030390.
FT   VARIANT     415    415       R -> Q. {ECO:0000269|PubMed:15077010}.
FT                                /FTId=VAR_043074.
FT   VARIANT     432    432       R -> T (in BRIC2; reduced transport
FT                                capacity for taurocholate).
FT                                {ECO:0000269|PubMed:16039748}.
FT                                /FTId=VAR_030391.
FT   VARIANT     444    444       V -> A (more frequent in patients with
FT                                drug-induced cholestasis than healthy
FT                                controls; associated with lower hepatic
FT                                expression; does not affect transport
FT                                capacity for taurocholate;
FT                                dbSNP:rs2287622).
FT                                {ECO:0000269|PubMed:11829140,
FT                                ECO:0000269|PubMed:15077010,
FT                                ECO:0000269|PubMed:16763017,
FT                                ECO:0000269|PubMed:16799996,
FT                                ECO:0000269|PubMed:17264802,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_013333.
FT   VARIANT     444    444       V -> D (in dbSNP:rs2287622).
FT                                /FTId=VAR_059106.
FT   VARIANT     444    444       V -> G (in dbSNP:rs2287622).
FT                                /FTId=VAR_059107.
FT   VARIANT     461    461       K -> E (in PFIC2).
FT                                {ECO:0000269|PubMed:9806540}.
FT                                /FTId=VAR_013334.
FT   VARIANT     482    482       D -> G (in PFIC2).
FT                                {ECO:0000269|PubMed:9806540}.
FT                                /FTId=VAR_013335.
FT   VARIANT     570    570       A -> T (in BRIC2).
FT                                {ECO:0000269|PubMed:15300568}.
FT                                /FTId=VAR_030392.
FT   VARIANT     591    591       N -> S (in a patient with intrahepatic
FT                                cholestasis of pregnancy;
FT                                dbSNP:rs11568367).
FT                                {ECO:0000269|PubMed:15077010}.
FT                                /FTId=VAR_043075.
FT   VARIANT     616    616       R -> G. {ECO:0000269|PubMed:16763017}.
FT                                /FTId=VAR_035350.
FT   VARIANT     619    619       T -> A. {ECO:0000269|PubMed:16763017}.
FT                                /FTId=VAR_035351.
FT   VARIANT     676    676       D -> Y (in fluvastatin-induced
FT                                cholestasis; does not affect transport
FT                                capacity for taurocholate).
FT                                {ECO:0000269|PubMed:17264802}.
FT                                /FTId=VAR_043076.
FT   VARIANT     677    677       M -> V (does not affect transport
FT                                capacity for taurocholate;
FT                                dbSNP:rs11568364).
FT                                {ECO:0000269|PubMed:15077010,
FT                                ECO:0000269|PubMed:16763017,
FT                                ECO:0000269|PubMed:16799996,
FT                                ECO:0000269|PubMed:17264802}.
FT                                /FTId=VAR_030393.
FT   VARIANT     698    698       R -> H (in dbSNP:rs138642043).
FT                                {ECO:0000269|PubMed:16763017,
FT                                ECO:0000269|PubMed:17264802}.
FT                                /FTId=VAR_035352.
FT   VARIANT     855    855       G -> R (in ethinylestradiol/gestodene-
FT                                induced cholestasis; loss of transport
FT                                capacity for taurocholate).
FT                                {ECO:0000269|PubMed:17264802}.
FT                                /FTId=VAR_043077.
FT   VARIANT     865    865       A -> V (in dbSNP:rs118109635).
FT                                {ECO:0000269|PubMed:16763017}.
FT                                /FTId=VAR_035353.
FT   VARIANT     923    923       T -> P (in BRIC2).
FT                                {ECO:0000269|PubMed:15300568}.
FT                                /FTId=VAR_030394.
FT   VARIANT     926    926       A -> P (in BRIC2).
FT                                {ECO:0000269|PubMed:15300568}.
FT                                /FTId=VAR_030395.
FT   VARIANT     958    958       R -> Q. {ECO:0000269|PubMed:16763017}.
FT                                /FTId=VAR_035354.
FT   VARIANT     982    982       G -> R (in PFIC2).
FT                                {ECO:0000269|PubMed:9806540}.
FT                                /FTId=VAR_013336.
FT   VARIANT    1004   1004       G -> D (in PFIC2).
FT                                {ECO:0000269|PubMed:11815775}.
FT                                /FTId=VAR_013337.
FT   VARIANT    1050   1050       R -> C (in BRIC2).
FT                                {ECO:0000269|PubMed:15300568}.
FT                                /FTId=VAR_030396.
FT   VARIANT    1128   1128       R -> H (in BRIC2).
FT                                {ECO:0000269|PubMed:15300568}.
FT                                /FTId=VAR_030397.
FT   VARIANT    1153   1153       R -> C (in PFIC2).
FT                                {ECO:0000269|PubMed:9806540}.
FT                                /FTId=VAR_013338.
FT   VARIANT    1186   1186       E -> K (in dbSNP:rs1521808).
FT                                /FTId=VAR_030398.
FT   VARIANT    1268   1268       R -> Q (in PFIC2).
FT                                {ECO:0000269|PubMed:9806540}.
FT                                /FTId=VAR_013339.
FT   CONFLICT    339    339       L -> V (in Ref. 1; AAC77455).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1321 AA;  146407 MW;  61EE2173E2351D80 CRC64;
     MSDSVILRSI KKFGEENDGF ESDKSYNNDK KSRLQDEKKG DGVRVGFFQL FRFSSSTDIW
     LMFVGSLCAF LHGIAQPGVL LIFGTMTDVF IDYDVELQEL QIPGKACVNN TIVWTNSSLN
     QNMTNGTRCG LLNIESEMIK FASYYAGIAV AVLITGYIQI CFWVIAAARQ IQKMRKFYFR
     RIMRMEIGWF DCNSVGELNT RFSDDINKIN DAIADQMALF IQRMTSTICG FLLGFFRGWK
     LTLVIISVSP LIGIGAATIG LSVSKFTDYE LKAYAKAGVV ADEVISSMRT VAAFGGEKRE
     VERYEKNLVF AQRWGIRKGI VMGFFTGFVW CLIFLCYALA FWYGSTLVLD EGEYTPGTLV
     QIFLSVIVGA LNLGNASPCL EAFATGRAAA TSIFETIDRK PIIDCMSEDG YKLDRIKGEI
     EFHNVTFHYP SRPEVKILND LNMVIKPGEM TALVGPSGAG KSTALQLIQR FYDPCEGMVT
     VDGHDIRSLN IQWLRDQIGI VEQEPVLFST TIAENIRYGR EDATMEDIVQ AAKEANAYNF
     IMDLPQQFDT LVGEGGGQMS GGQKQRVAIA RALIRNPKIL LLDMATSALD NESEAMVQEV
     LSKIQHGHTI ISVAHRLSTV RAADTIIGFE HGTAVERGTH EELLERKGVY FTLVTLQSQG
     NQALNEEDIK DATEDDMLAR TFSRGSYQDS LRASIRQRSK SQLSYLVHEP PLAVVDHKST
     YEEDRKDKDI PVQEEVEPAP VRRILKFSAP EWPYMLVGSV GAAVNGTVTP LYAFLFSQIL
     GTFSIPDKEE QRSQINGVCL LFVAMGCVSL FTQFLQGYAF AKSGELLTKR LRKFGFRAML
     GQDIAWFDDL RNSPGALTTR LATDASQVQG AAGSQIGMIV NSFTNVTVAM IIAFSFSWKL
     SLVILCFFPF LALSGATQTR MLTGFASRDK QALEMVGQIT NEALSNIRTV AGIGKERRFI
     EALETELEKP FKTAIQKANI YGFCFAFAQC IMFIANSASY RYGGYLISNE GLHFSYVFRV
     ISAVVLSATA LGRAFSYTPS YAKAKISAAR FFQLLDRQPP ISVYNTAGEK WDNFQGKIDF
     VDCKFTYPSR PDSQVLNGLS VSISPGQTLA FVGSSGCGKS TSIQLLERFY DPDQGKVMID
     GHDSKKVNVQ FLRSNIGIVS QEPVLFACSI MDNIKYGDNT KEIPMERVIA AAKQAQLHDF
     VMSLPEKYET NVGSQGSQLS RGEKQRIAIA RAIVRDPKIL LLDEATSALD TESEKTVQVA
     LDKAREGRTC IVIAHRLSTI QNADIIAVMA QGVVIEKGTH EELMAQKGAY YKLVTTGSPI
     S
//
